The need of systemic change in health care has been well recognized in most Western Countries. The key drivers of change relate to population ageing, technological development, changing expectations towards services and the political strive to put a damper on the growth of the GDP share of health expenditure. The publication sheds light on challenges in management of systemic innovation. [More]

Research and Markets has announced the addition of the "Bahrain Pharmaceuticals and Healthcare Report Q4 2009" report to their offering. [More]

In addition to ageing demographics and higher incidence of vision disorders, key factors underpinning demand for ophthalmic instrumentation include development of innovative technologies and procedures, especially in vision correction surgery, growing recognition of laser surgery, and the trend towards permanent visual correction. [More]

Adults aged 50 and over accounted for 34% of the total UK population in 2007. Official forecasts indicate that the number of UK residents aged 45 and over will increase by 7.7% between 2008 and 2013, meaning that the over-50s are an increasingly important group for companies to target. [More]

Research and Markets has announced the addition of the "Wound Treatments in the Netherlands" report to their offering. [More]

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth. [More]

Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market. [More]

Melatonin, a natural hormone segregated by the own human body, is an excellent sleep regulator expected to replace somniferous, which are much more aggressive, to correct the sleep/wakefulness pace when human biological clock becomes altered. [More]

Research and Markets (http://www.researchandmarkets.com/research/dc1a16/the_pharmaceutical) has announced the addition of the "The Pharmaceutical Market: Japan" report to their offering. [More]

As many as one in seven people will experience tinnitus, or ringing in their ears, at some time of their life, but not enough is being done to support patients who experience this distressing condition, according to an extensive research review in the November issue of the Journal of Clinical Nursing. [More]

As many as one in seven people will experience tinnitus, or ringing in their ears, at some time of their life, but not enough is being done to support patients who experience this distressing condition, according to an extensive research review in the November issue of the Journal of Clinical Nursing. [More]

Research and Markets (http://www.researchandmarkets.com/research/dbe80f/china_pharmaceutic) has announced the addition of the "China Pharmaceuticals and Healthcare Report Q4 2009" report to their offering. [More]

Research and Markets (http://www.researchandmarkets.com/research/601374/the_top_60_europea) has announced the addition of the "The Top 60 European Manufacturers Of Generic Pharmaceuticals" report to their offering. [More]

The theme of this year's World Stroke Day on 29th October is "What can I do?". As the World Stroke Organization says, everyone can do something: learn to recognise symptoms and take action, learn to recognise the risk factors and take action. [More]

Research and Markets (http://www.researchandmarkets.com/research/a641bf/wireless_ehealth_a) has announced the addition of the "Wireless eHealth and the Elderly Consumer" report to their offering. [More]